Skip to main content
Premium Trial:

Request an Annual Quote

Altogen Biosystems, Invitrogen

Premium
Altogen Biosystems has recently introduced a new in vivo nanoparticle-based transfection reagent for use in delivering DNA or RNA, including siRNAs.
 
According to the company, the nanoparticles allow DNA or RNA to be systemically delivered into animal tissues, as well as through intraperitoneal and direct intratumoral injections.
 

 
Invitrogen has launched NCode human and mouse non-coding RNA microarrays.
 
According to the company, the microarrays, which are manufactured by Agilent Technologies, consist of both non-coding RNA and messenger RNA content.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.